Clinical Research Directory
Browse clinical research sites, groups, and studies.
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
Sponsor: Baker Heart and Diabetes Institute
Summary
This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.
Official title: Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE): A Randomised Controlled Trial of the Role of Optimal Cardioprotection Strategies to Prevent Heart Failure
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
820
Start Date
2021-11-18
Completion Date
2025-12-30
Last Updated
2025-10-03
Healthy Volunteers
Yes
Conditions
Interventions
Heart Failure intervention (Cardiac COVID Disease Management Plan (CC-DMP)
A clinical review to ensure optimal risk factor control and cardioprotection along with exercise intervention.
Usual care
This will be provided by participants' usual healthcare professional(s).
Locations (1)
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia